Log In
Print this Print this

lumretuzumab (RG7116)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionAnti-HER3/ADCC humanized mAb
Molecular Target Epidermal growth factor receptor 3 (EGFR3) (HER3) (ErbB3)
Mechanism of ActionAntibody; Epidermal growth factor (EGF) receptor 3 (HER3) (ErbB3) inhibitor; Antibody dependent cellular cytotoxicity (ADCC)
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today